A Change of Heart: Emerging Strategies in the Management of CV Risk in Type 2 Diabetes

1. In patients with type 2 diabetes and established cardiovascular disease (CVD) or CVD risk, large cardiovascular outcome trials have demonstrated improved cardiovascular outcomes with the following antihyperglycemic agents:
A. Empagliflozin
B. Liraglutide
C. Canagliflozin
D. Lixisenatide
E. A, B and C
F. All of the above
{"name":"A Change of Heart: Emerging Strategies in the Management of CV Risk in Type 2 Diabetes", "url":"https://www.quiz-maker.com/QPREVIEW","txt":"1. In patients with type 2 diabetes and established cardiovascular disease (CVD) or CVD risk, large cardiovascular outcome trials have demonstrated improved cardiovascular outcomes with the following antihyperglycemic agents:","img":"https://www.quiz-maker.com/3012/images/ogquiz.png"}
Powered by: Quiz Maker